TNF and chronic obstructive pulmonary disease: PDE4 inhibitors can exert a range of anti-inflammatory effects relevant to the neutrophilic inflammatory milieu in COPD, including inhibition of TNF production by alveolar macrophages and monocytes and inhibition of ROS production by neutrophils [104].